ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

Prostate Cancer

Prostatectomy pathology findings in an active surveillance population - Abstract

OBJECTIVES: The difficulty in predicting indolent prostate cancer leads to the use of different inclusion criteria in an active surveillance (AS) program.

Read more...

Prostate cancer outcomes in France: Treatments, adverse effects and two-year mortality - Abstract

BACKGROUND: This very large population-based study investigated outcomes after a diagnosis of prostate cancer (PCa) in terms of mortality rates, treatments and adverse effects.

Read more...

Perceptions of active surveillance and treatment recommendations for low-risk prostate cancer: Results from a national survey of radiation oncologists and urologists - Abstract

BACKGROUND: With the growing concerns about overtreatment in prostate cancer, the extent to which radiation oncologists and urologists perceive active surveillance (AS) as effective and recommend it to patients are unknown.

Read more...

Evolution of androgen receptor targeted therapy for advanced prostate cancer - Abstract

The discovery of androgen dependence in prostate cancer in 1941 by Huggins and colleagues has remained the backbone for the treatment of this disease.

Read more...

Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: New findings from an updated meta-analysis - Abstract

PURPOSE: To investigate and clarify the relationship between circulating 25-hydroxyvitamin D level and prostate cancer risk.

Read more...

Criticisms to patient selection in active surveillance in prostate cancer - Abstract

OBJECTIVES: Active treatment in localized prostate cancer, in its various types, is assumed as a valid alternative.

Read more...

Economic features of active surveillance - Abstract

In a context where there is evidence that not every patient with low risk prostate cancer needs to be treated from the start, active treatments are expensive and public health care systems need to save money, studies on cost-effectiveness are a priority.

Read more...

Endopelvic fascia preservation during robot-assisted laparoscopic radical prostatectomy: Does it affect urinary incontinence? - Abstract

Objective: Urinary incontinence has a significant impact on the quality of life after radical prostatectomy.

Read more...

Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy - Abstract

Aim: To examine the role of the new grading system Prostate Cancer Risk Index (PRIX) with existing risk-grouping after high-dose-rate interstitial brachytherapy (HDR-ISBT) as monotherapy for localized prostate cancer.

Read more...

Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: A controlled comparison - Abstract

OBJECTIVE: Prostate cancer patients who receive androgen deprivation therapy (ADT) often experience many physical and psychological side effects.

Read more...

Page 1 of 959